Kimia Farma Tbk PT
IDX:KAEF

Watchlist Manager
Kimia Farma Tbk PT Logo
Kimia Farma Tbk PT
IDX:KAEF
Watchlist
Price: 610 IDR Market Closed
Market Cap: 3.4T IDR
Have any thoughts about
Kimia Farma Tbk PT?
Write Note

Relative Value

The Relative Value of one KAEF stock under the Base Case scenario is 1 913.66 IDR. Compared to the current market price of 610 IDR, Kimia Farma Tbk PT is Undervalued by 68%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

KAEF Relative Value
Base Case
1 913.66 IDR
Undervaluation 68%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
95
vs Industry
86
Median 3Y
0.5
Median 5Y
0.7
Industry
2.5
vs History
vs Industry
0
Median 3Y
-2.5
Median 5Y
-2.5
Industry
21.9
vs History
50
vs Industry
Median 3Y
6.5
Median 5Y
6.5
Industry
16.5
vs History
vs Industry
Median 3Y
-2
Median 5Y
5.7
Industry
23.6
vs History
79
vs Industry
72
Median 3Y
0.8
Median 5Y
1
Industry
2.1
vs History
95
vs Industry
74
Median 3Y
1.1
Median 5Y
1.3
Industry
2.6
vs History
46
vs Industry
59
Median 3Y
3.6
Median 5Y
3.8
Industry
5.2
vs History
vs Industry
27
Median 3Y
16.2
Median 5Y
20.8
Industry
13.3
vs History
vs Industry
31
Median 3Y
16.2
Median 5Y
20.8
Industry
16.6
vs History
50
vs Industry
Median 3Y
16.7
Median 5Y
16.7
Industry
15.6
vs History
12
vs Industry
Median 3Y
-19.6
Median 5Y
-12.2
Industry
19.1
vs History
69
vs Industry
72
Median 3Y
0.7
Median 5Y
0.9
Industry
1.9

Multiples Across Competitors

KAEF Competitors Multiples
Kimia Farma Tbk PT Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ID
Kimia Farma Tbk PT
IDX:KAEF
3.4T IDR 0.3 -2 -4.4 -4.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
ID
Kimia Farma Tbk PT
IDX:KAEF
Average P/E: 32.4
Negative Multiple: -2
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top